Imperial College London

ProfessorPeterSever

Faculty of MedicineNational Heart & Lung Institute

Professor of Clinical Pharmacology & Therapeutics
 
 
 
//

Contact

 

+44 (0)20 7594 1099p.sever

 
 
//

Assistant

 

Mrs Yvonne Green +44 (0)20 7594 1100

 
//

Location

 

333ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Giugliano:2020:10.1161/STROKEAHA.119.027759,
author = {Giugliano, RP and Pedersen, TR and Saver, JL and Sever, PS and Keech, AC and Bohula, EA and Murphy, SA and Wasserman, SM and Honarpour, N and Wang, H and Lira, Pineda A and Sabatine, MS},
doi = {10.1161/STROKEAHA.119.027759},
journal = {STROKE},
pages = {1546--1554},
title = {Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis},
url = {http://dx.doi.org/10.1161/STROKEAHA.119.027759},
volume = {51},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Giugliano,RP
AU - Pedersen,TR
AU - Saver,JL
AU - Sever,PS
AU - Keech,AC
AU - Bohula,EA
AU - Murphy,SA
AU - Wasserman,SM
AU - Honarpour,N
AU - Wang,H
AU - Lira,Pineda A
AU - Sabatine,MS
DO - 10.1161/STROKEAHA.119.027759
EP - 1554
PY - 2020///
SN - 0039-2499
SP - 1546
TI - Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
T2 - STROKE
UR - http://dx.doi.org/10.1161/STROKEAHA.119.027759
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530437900055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 51
ER -